Trial Profile
Role of mifepristone (RU 486) in management of uterine leiomyoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 19 Apr 2012 New trial record